(Q33341515)

English

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches (English)

1 reference

Europe PubMed Central

25 July 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

object named as

Yasuharu Imai

1 reference

Europe PubMed Central

25 July 2017

10

object named as

Morito Monden

1 reference

Europe PubMed Central

25 July 2017

5

object named as

Koji Umeshita

1 reference

Europe PubMed Central

25 July 2017

3

object named as

Keizo Dono

1 reference

Europe PubMed Central

25 July 2017

4

object named as

Shoji Nakamori

1 reference

Europe PubMed Central

25 July 2017

author name string

Masato Sakon

1

1 reference

Europe PubMed Central

25 July 2017

Hiroaki Nagano

2

1 reference

Europe PubMed Central

25 July 2017

Akira Yamada

6

1 reference

Europe PubMed Central

25 July 2017

Sumio Kawata

7

1 reference

Europe PubMed Central

25 July 2017

Shohei Iijima

9

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

94

1 reference

Europe PubMed Central

25 July 2017

435-442

1 reference

Europe PubMed Central

25 July 2017

2

1 reference

Europe PubMed Central

25 July 2017

Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

21 January 2018

Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by transcatheter arterial chemo-embolization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-surgical treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrahepatic chemotherapy for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Intra-arterial and intravenous use of 4' epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinoma. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomy for hepatocellular carcinoma. A further report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of recombinant leukocyte interferon plus doxorubicin in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergetic effects of retrovirus IFN-alpha gene transfer and 5-FU on apoptosis of colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon effects upon fluorouracil metabolism by HL-60 cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10246

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.10246

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33341515&oldid=1991388488"